W. Soudijn - Concepedia

Author

W. Soudijn

Janssen (Belgium)

Also Known As

W SOUDIJN, W Soudijn, W. SOUDIJN, W. Soudijn, WILLEM SOUDIJN, Willem Soudijn

129

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Leiden University Centre for Human Drug Research University of Amsterdam Solvay (Netherlands)

About

W. Soudijn is an author at Janssen (Belgium) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	38	1.1K
2	Natural Sciences	8	8	216
3	Health Sciences	5	5	259
4	Social Sciences	5	5	105
5	Engineering	1	1	19

W. Soudijn

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Distribution, excretion and metabolism of neuroleptics of the butyrophenone type W. Soudijn, I. van Wijngaarden, F. Allewijn European Journal of Pharmacology Butyrophenone TypeNeuropeptidesNeurophysiologyNeuroanatomyPhysiology	1967	122
Ribose-Modified Adenosine Analogs as Potential Partial Agonists for the Adenosine Receptor Eleonora M. van der Wenden, Jacobien K. von Frijtag Drabbe Kuenzel, Ron A. A. Mathôt, Journal of Medicinal Chemistry	1995	73
Angiotensin converting enzyme inhibitors W. Soudijn Pharmacy World & Science HypertensionMedicineAntihypertensive TherapyCardiovascular PharmacologyPharmacotherapy	1982	72
1H-Imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists Philip J. M. van Galen, P.J.A. Nissen, I. van Wijngaarden, Journal of Medicinal Chemistry	1991	62
Distribution excretion and metabolism of neuroleptics of the butyrophenone type Georg Braun, George I. Poos, W. Soudijn European Journal of Pharmacology NeuropeptidesDistribution ExcretionNeurophysiologyMedicinePhysiology	1967	59
Influence of the molecular structure of N6-(ω-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activity Adriaan P. IJzerman, Philip J. M. van Galen, W. Soudijn European Journal of Pharmacology Molecular Pharmacology Molecular PharmacologyAdenosine Receptor AffinityMolecular PhysiologySignal TransductionBiochemistry	1989	51
Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat. Ron A. A. Mathôt, E.A. van Schaick, M.W.E. Langemeijer, Journal of Pharmacology and Experimental Therapeutics	1994	49
Structure-Affinity Relationship Studies on 5-HT1A receptor Ligands. 2. Heterobicyclic Phenylpiperazines with N4-Aralkyl Substituents Bart J. van Steen, I. van Wijngaarden, M.Th.M. Tulp, Journal of Medicinal Chemistry	1994	48
Suramin analogs, divalent cations and ATPγS as inhibitors of ecto-ATPase Margot W. Beukers, Cornel J. M. Kerkhof, M. Rhee, Naunyn-Schmiedeberg s Archives of Pharmacology Molecular PharmacologyBiochemistryMedicineNatural SciencesMechanism Of Action	1995	46
A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties Philip J. M. van Galen, Herman van Vlijmen, Adriaan P. IJzerman, Journal of Medicinal Chemistry	1990	46

Page 1